The importance of serum procalcitonin levels in patients with chronic obstructive pulmonary disease exacerbations

Turkish Journal of Medical Sciences

Volumn 38, Issue 2, 2008, Pages 139-144

  Taşçi, Cantürk ^a   Balkan, Arzu ^b   Karadurmuş, Nuri ^a   Inal, Satilmiş ^a   Kiliç, Selim ^b   Özkan, Metin ^b   Bigiç, Hayati ^b   Ekiz, Kudret ^b  

^a Military Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute exacerbation; Acute phase reactants; COPD; Procalcitonin

Indexed keywords

BACTERIA; BIOCHEMICAL ENGINEERING; PATIENT TREATMENT; PULMONARY DISEASES; SEDIMENTATION;

ACUTE EXACERBATION; ACUTE PHASE REACTANTS; PROCALCITONIN;

BLOOD;

ACUTE PHASE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LUNG INFECTION; MALE; MEASUREMENT; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; THORAX RADIOGRAPHY; TREATMENT PLANNING;

EID: 44149123850     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2006.
2. Zarka V, Valat C, Lemaria E, Boissinot E, Carre P, Besnart JC et al. Procalcitonin and respiratory tract infections. Rev Pneumol Clin 1999; 55(6): 365-9.
3. Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent JL. Procalcitonin used as a marker of infections in the intensive care unit. Crit Care Med 1999; 27(3): 498-504.
4. Van Leeuwen HJ, Voorbij HA. Procalcitonin concentrations in the diagnosis of acute inflammatory reactions. Ned Tijdschr Geneeskd 2002; 146(2): 55-9.
5. Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings. Peditr Pulmonol 2003; 35(1): 56-61.
6. Baylan O, Albay A, Kisa Ö, Doǧanci L. Prokalsitonin; Gülhane Askeri Tip Akademisi Ayin Kitabi Ekim 2002; Sayi: 31, Sayfa: 1-51.
7. Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002; 8(2): 93-100.
8. Becker KL, Nylen ES, Cohen R, Snider RH. Calcitonin: structure, molecular biology and actions. In: Bilezikian J, Raisz LG, Rodan GA, editors. Principles of Bone Biology. San Diego, CA: Academic Press Inc.; 1996. pp. 471-4.
9. Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20: 1-9.
10. Meisner M. Procalcitonin (PCT): a new innovative infection parameter biochemical and clinical aspects, 3rd ed. Stuttgart: Georg Thieme; 2000. pp. 1-196.
11. Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P. Procalcitonin and CRP as markers of systemic inflammatory response syndrome severity in critical ill children. Intensive Care Med 2007; 33: 477-84.
12. Gendrel D, Raymond J, Assicot M, Moulin F, Iniquez JL, Lebon P. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-2.
13. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg 2007; 50(1): 34-41.
14. Boussekey N, Leroy O, Alfandari S, Devos P, Georges H, Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006; 32: 469-72.
15. Heper Y, Akalin EH, Mistik R, Akgöz S, Tore O, Goral G et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006 Aug; 25(8): 481-91.
16. Müller B, Prat C. Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin. Clin Microbiol Infect 2006; 12 (Suppl 9): 8-16.
17. Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P, Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006; 39(12): 1138-43.
18. Dwolatzky T, Olshtain-Pops K, Yinnon AM, Raveh D, Rogowski O, Shapira I et al. Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections. Eur J Clin Microbiol Infect Dis 2005; 24: 763-5.
19. Müller B, Prat C. Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin. Clin Microbiol Infect 2006; 12 (Suppl 9): 8-16.
20. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174(1): 84-93.
21. Briel M, Christ-Crain M, Young J, Schuetz P, Huber P, Periat P et al. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomized controlled trial and baseline characteristics of participating general practitioners. BMJ Fam Pract 2005; 6: 34.
22. Gaini S, Koldkjaer OG, Pedersen C, Pedersen SS. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6, and C-reactive protein in community-acquired infections and sepsis: a prospective study. Critic Care 2006; 10(2): R53.
23. Toikka P, Irjala K, Juven T, Virrki R, Mertsola P, Leinonen M et al. Serum procalcitonin, C-reactive protein and interleukin 6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 598-602.
24. Chang C, Yao WZ, Chen YH, Liu ZY, Zhang XW. The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease. Zhoungha Jie He He Hu Xi Za Zhi 2006; 29(7): 444-7.
25. Chang C, Yao WZ, Chen YH, Liu ZY, Zhang XW. Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of chronic obstructive pulmonary disease. Beijing Da Xue Xue Bao 2006; 38(4): 389-92.
26. Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003; 21(6): 939-43.
27. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34(10): 2596-602.
28. Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P, Luzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006; 39: 1138-43.